Uniqure N V Revenue per Employee (QURE), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Uniqure N v   (NASDAQ: QURE)
 

Uniqure N V 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 40.39% in the third quarter 2026, year on year to cumulative value of $20 million, Uniqure N V 's revenue per employee grew on a trailing twelve months basis to $ 91,253. The productivity of Uniqure N V 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 281 other companies have achieved higher revenue per employee. While Uniqure N V 's total ranking has deteriorated compared to the previous quarter from 2001 to 2034. Uniqure N V has 221 employees.


What is Sales per Employee Ratio?







QURE Revenue per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Revenue Change 40.39 % 11 % 127.31 % 6.65 % 61.83 %
Sales per Employee (TTM) $ 91,253 84,489 81,869 72,842 71,271
QURE's Total Ranking # 2034 # 2001 # 1895 # #
Seq. Revenue Change -11.04 % 63.98 % -36.03 % 50.45 % -29.67 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 106
Healthcare Sector # 282
Overall Market # 2034

Revenue per Employee Statistics
High Average Low
$ 2,377,104 $ 401,810 $ 17,566
(Mar 31 2022)   (Mar 31 2021)



Financial Statements
Uniqure N V 's Revenue MRQ $ 5 Millions Visit QURE's Income Statement
Uniqure N V 's Revenues TTM $ 20 Millions Visit QURE's aggregate revenue growth
What are QURE's Sales? Visit QURE's Sales by Segment




Other Ratios
Uniqure N V 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
QURE's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for QURE's Competitors
Revenue per Employee for QURE's Suppliers
Revenue per Employee for QURE's Customers

You may also want to know
QURE's Sales Growth Rates QURE's Pe Price to earnings ratio QURE's Receivables Turnover Ratio QURE's Stock Quote
QURE's Net Income Growth Rates QURE's Ps Price to Sales ratio QURE's Sales per Employee QURE's Asset Turnover Ratio
QURE's Net Margin QURE's Pb Price to Book ratio QURE's Financial Strength Ratios QURE's Dividend Payout Ratio
Date modified: 2026-11-06T13:00:36+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Lifestance Health Group Inc   152,986.86 $ 1,676.889  Million 10,961 
Encompass Health Corporation  150,907.14 $ 6,338.100  Million 42,000 
Profound Medical Corp   145,845.68 $ 23.627  Million 162 
Intellia Therapeutics Inc   140,283.82 $ 52.887  Million 377 
Crispr Therapeutics Ag  125,233.83 $ 25.172  Million 201 
Sonida Senior Living Inc   124,149.81 $ 638.130  Million 5,140 
Ensign Group Inc  123,354.46 $ 5,674.305  Million 46,000 
Abcellera Biologics Inc   120,743.77 $ 67.858  Million 562 
Pacs Group Inc   120,220.19 $ 5,705.049  Million 47,455 
U S Physical Therapy Inc  114,838.09 $ 837.629  Million 7,294 
Recursion Pharmaceuticals Inc   113,720.00 $ 68.232  Million 600 
Amarin Corp Plcuk  107,035.76 $ 176.609  Million 1,650 
Aclaris Therapeutics Inc   87,684.93 $ 6.401  Million 73 
Biomerica Inc   86,760.00 $ 4.338  Million 50 
Teleflex Incorporated  82,817.74 $ 1,283.675  Million 15,500 
Lenz Therapeutics Inc   81,309.21 $ 12.359  Million 152 
Healthcare Services Group Inc   52,218.33 $ 1,879.860  Million 36,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.